Descriptor English: | Cysteinyldopa | ||||
Descriptor Spanish: |
Cisteinildopa
| ||||
Descriptor Portuguese: | Cisteinildopa | ||||
Descriptor French: | 5-((2-Amino-2-carboxyéthyl)sulfanyl)-3-hydroxy-tyrosine | ||||
Entry term(s): |
5 S Cysteinyldopa 5-S-Cysteinyldopa |
||||
Tree number(s): |
D02.092.311.200.180 D02.455.426.559.389.657.166.175.200.180 D02.886.030.230.330 D12.125.072.050.685.400.180 D12.125.072.050.875.130.180 D12.125.166.230.330 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D003548 | ||||
Scope note: | Found in large amounts in the plasma and urine of patients with malignant melanoma. It is therefore used in the diagnosis of melanoma and for the detection of postoperative metastases. Cysteinyldopa is believed to be formed by the rapid enzymatic hydrolysis of 5-S-glutathionedopa found in melanin-producing cells. |
||||
Annotation: | /biosyn /physiol permitted |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Registry Number: | 19641-92-0 | ||||
CAS Type 1 Name: | L-Tyrosine, 3-((2-amino-2-carboxyethyl)thio)-5-hydroxy-, (R)- | ||||
Previous Indexing: |
Cysteine (1966-1976) Dopa (1966-1976) |
||||
Public MeSH Note: | 91; was see under DOPA 1977-90 |
||||
History Note: | 91(77); was see under DOPA 1977-90 |
||||
DeCS ID: | 3566 | ||||
Unique ID: | D003548 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1991/01/01 | ||||
Date of Entry: | 1976/04/27 | ||||
Revision Date: | 2018/06/30 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Cysteinyldopa
- Preferred
Concept UI |
M0005549 |
Scope note | Found in large amounts in the plasma and urine of patients with malignant melanoma. It is therefore used in the diagnosis of melanoma and for the detection of postoperative metastases. Cysteinyldopa is believed to be formed by the rapid enzymatic hydrolysis of 5-S-glutathionedopa found in melanin-producing cells. |
Preferred term | Cysteinyldopa |
Entry term(s) |
5 S Cysteinyldopa 5-S-Cysteinyldopa |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey